Aureus Asset Management »

Ocuphire Pharma shares owned by Aureus Asset Management

Quarter-by-quarter ownership of Ocuphire Pharma (IRD) shares owned by Aureus Asset Management from 13F filings

Historical chart of Aureus Asset Management investment in Ocuphire Pharma

Tip: Access up to 7 years of quarterly data

All positions including Ocuphire Pharma held by Aureus Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ocuphire Pharma by Aureus Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $239k 58k 4.11

More positions owned by Aureus Asset Management

Alphabet Cap Stk Cl A (GOOGL)
Applied Materials (AMAT)
Apple (AAPL)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Visa Com Cl A (V)
Broadcom (AVGO)
Charles Schwab Corporation (SCHW)
Linde SHS (LIN)
Waste Connections (WCN)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
UnitedHealth (UNH)
Nextera Energy (NEE)
NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)

View all positions for Aureus Asset Management

Top funds holding Ocuphire Pharma

Caligan Partners
Adage Capital Partners GP
BIOS Capital Management
BlackRock
Balyasny Asset Management
Nantahala Capital Management
Vanguard Capital Management
Boxer Capital Management
Trails Edge Capital Partners
Millennium Management
Dr. Jeffrey R. Jay, M.D.
Marshall Wace
ADAR1 Capital Management
Goldman Sachs Group
Woodline Partners

View all funds holding Ocuphire Pharma